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Matthias Voehringer, MD,* Udo Sechtem, MD*
Stuttgart, Germany; and London, United Kingdom
Objectives We sought to determine the prognosis of patients with acute coronary syndrome without culprit lesion and proof
of coronary spasm during 3 years of follow-up.
Background Coronary artery spasm has been identified as an alternative cause for acute coronary syndrome (ACS) in pa-
tients without culprit lesion. In the CASPAR (Coronary Artery Spasm as a Frequent Cause for Acute Coronary Syn-
drome) study, we recently showed that 50% of ACS patients without culprit lesion, in whom intracoronary ace-
tylcholine provocation was performed, had coronary spasm. However, data on prognosis in these patients are
sparse.
Methods After 3 years of follow-up, data regarding the following end points were obtained: death (cardiac and noncar-
diac), nonfatal myocardial infarction, and recurrent angina leading to repeated coronary angiography. The analy-
sis focused on patients with a culprit lesion (n  270) and patients without a culprit lesion (n  76) but with
acetylcholine provocation (total n  346).
Results In patients without culprit lesion, there was no cardiac death or nonfatal myocardial infarction during follow-up;
1 patient died due to a noncardiac cause. However, 38 of 76 patients reported persistent angina requiring re-
peated angiography in 3 cases (3.9%). Thirty of 270 patients with culprit lesion died due to a cardiac cause
(11.1%) and 13 due to a noncardiac cause (4.8%). Eleven patients had nonfatal myocardial infarction (4.1%)
and 27 repeated angiography due to persistent or recurrent angina (10%). Patients with a culprit lesion had a
higher mortality and more coronary events compared with those without (p  0.0005, log-rank test).
Conclusions ACS patients without culprit lesion and proof of coronary spasm have an excellent prognosis for survival and cor-
onary events after 3 years compared with patients with obstructive ACS. However, persistent angina represents
a challenging problem in these patients, leading in some cases to repeated coronary angiography. (J Am Coll
Cardiol 2011;57:147–52) © 2011 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2010.08.626e
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bespite improvements in diagnosis and therapy over the last
ears, mortality among patients with acute coronary syn-
rome (ACS) is still high (1,2). Among others, we could
ecently show that ACS patients frequently have no culprit
esion and that these patients often suffer from coronary
rtery spasm as an explanation for their acute chest pain
3,4). The CASPAR (Coronary Artery Spasm as a Frequent
ause for Acute Coronary Syndrome) study (4) revealed no
ulprit lesion in 138 out of 488 ACS patients undergoing
rom the *Department of Cardiology, Robert-Bosch-Krankenhaus, Stuttgart, Ger-
any; and the †Clinical Trials Unit, St. George’s University of London, London,
nited Kingdom. The authors have reported that they have no relationships to
isclose.c
Manuscript received March 8, 2010; revised manuscript received August 3, 2010,
ccepted August 10, 2010.mergency coronary angiography, and 86 underwent intra-
oronary acetylcholine (ACH) provocation for the detection
f coronary spasm, which was positive in 42 patients (49%).
Regarding outcome, however, there are only a few studies
n a similar cohort of patients. Wang et al. (3) reported 93
apanese ACS patients with insignificant coronary artery
isease who underwent intracoronary ergonovine testing for
he detection of coronary spasm. Thirty-eight patients had
positive test (41%). After a median follow-up of 25
onths, there were no cardiac deaths, but there were 3
onfatal myocardial infarctions, 2 of them in the spasm
roup. However, it is unclear whether these results can be
xtrapolated to Caucasian patients, as racial differences have
een described between Asian and Caucasian patients with
oronary spasm (5). Consequently, we determined the
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tients of the CASPAR study
during 3 years of follow-up.
Methods
The design of the CASPAR
study has been reported previ-
ously (4). Epicardial coronary
spasm was defined as 75% cor-
onary diameter reduction during
ACH infusion in comparison to
the relaxed state after intracoro-
nary nitroglycerin administration
together with a reproduction of
the patient’s initial symptoms.
The degree of vasoconstriction
was quantitatively analyzed with
QCA-CMS version 7.0 (Medis-
oftware, Leiden, the Netherlands).
ollow-up. Patient follow-up data were obtained using a
ritten questionnaire. Additional information was obtained
rom medical records of outpatient visits or of hospital
eadmissions. In patients for whom none of these data were
vailable, information was obtained by calling the patient or
he patient’s general practitioner. All information was ob-
ained between June and December 2009, 3 years after study
ntry. The end points were defined as death, nonfatal
yocardial infarction, and recurrent angina pectoris leading
Abbreviations
and Acronyms
ACH  acetylcholine
ACS  acute coronary
syndrome
ECG  electrocardiogram
LCA  left coronary artery
NSTEMI  non–ST-segment
elevation myocardial
infarction
STEMI  ST-segment
elevation myocardial
infarction
TIMI  Thrombolysis In
Myocardial Infarction
UAP  unstable angina
pectoris
Figure 1 Study Flow Chart
ACH  acetylcholine; CASPAR  Coronary Artery Spasm in Patients With Acute Coo repeated coronary angiography. The cause of death was
urther classified as cardiac or noncardiac according to the
atient medical records, death certificates, or information by
he general practitioner. Coronary events were defined as a
ombination of cardiac death and nonfatal myocardial
nfarction.
Of all 488 patients from the initial study, follow-up
ocused on patients with culprit lesion (n  350) and
atients without culprit lesion (n  86) but with an ACH
est. Follow-up data were available in 346 patients (79.4%)
f whom 270 patients belonged to the group with culprit
esion (77% follow-up) and 76 patients to the group without
ulprit lesion (88% follow-up) (Fig. 1).
redictors for outcome in patients without culprit lesion.
n patients without culprit lesion who underwent ACH
esting, the following binary parameters were obtained for
ater outcome analysis: reproduction of angina during ACH
esting, presence of ischemic electrocardiogram (ECG)
hifts during ACH testing (ST-segment depression or
T-segment elevation of 1 mm in at least 2 contiguous
eads), and presence of the slow coronary flow phenomenon
efined as a Thrombolysis In Myocardial Infarction (TIMI)
rame count of 27 frames in at least 1 coronary artery
ccording to Gibson et al. (6).
tatistical analysis. Data analysis was performed utilizing
PSS version 16.0 (SPSS Inc., Chicago, Illinois). Results
re expressed as mean SD. The Fisher exact test was used
or categorical variables. The t test was used to compare
Syndrome.ronary
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January 11, 2011:147–52 ACS Patients With Coronary Spasm: 3-Year Follow-Upontinuous variables. For values without normal distribu-
ion, median and interquartile ranges are stated, and Mann-
hitney U test was used. Kaplan-Meier curves were calcu-
ated for visualizing overall survival as well as freedom from
oronary events of patients compared with those without
ulprit lesion. A log-rank test was performed to compare
oth curves. After univariate analysis, multivariate Cox
egression analysis was carried out for the identification of
ndependent predictors of outcome. A 2-tailed p value
0.05 was considered significant.
esults
f the 86 patients who underwent ACH testing in the
nitial study, 42 showed epicardial coronary spasm with
eproduction of the initial symptoms. Patients with a
egative ACH test reported reproduction of symptoms in
7 of 44 patients (39%), and an intermediate vasoconstric-
ion without reproduction of symptoms was observed in 15
f 44 patients (34%) during initial ACH infusion. Eight
atients had significant epicardial vasoconstriction without
eproduction of symptoms, and 4 patients had no symptoms
nd no relevant vasoconstriction on ACH testing.
ollow-up. The results regarding the end points are shown
n Tables 1 and 2. Fifty-two patients died during follow-up
Patient Main Clinical CharacteristicsTable 1 Patient Main Clinical Characteristic
Culprit Lesion Presen
n 270
Male 191 (71%)
Age (yrs) 69 (61–77)
LVEF 57 (44–70)
Troponin I (normal 0.16 /l)* 6.15 (0.45–45.7)
Death 51 (19%)
Cardiac death 30 (11%)
Nonfatal myocardial infarction 11 (4.1%)
Persistent angina 78 (28.9%)
Repeated coronary angiography 27 (10%)
Values are n, n (%), or median (interquartile range). *Normal troponin
LVEF  left ventricular ejection fraction.
Clinical Characteristics of Patients Without CulTable 2 Clinical Characteristics of Patients
Epicard
Prese
n 37
Male 18 (49%
Age (yrs) 61 (53–7
LVEF 70 (62–7
Troponin I* 0.02 (0.02
Death 0
Cardiac death 0
Nonfatal myocardial infarction 0
Persistent angina 17 (46%
Repeated coronary angiography 1 (2.7%Values are n, n (%), or median (interquartile range). *Normal troponin I 0.1
ACH  acetylcholine; other abbreviations as in Table 1.15%), 14 due to a noncardiac cause (4%) (septic shock
ollowing pneumonia [n  2], multiorgan failure after
astrointestinal operation [n  4], pulmonary sarcoma
n 1], pulmonary embolism [n 1], cancer [n 6]). The
ause of death could not be ascertained in 8 patients, all of
hom belonged to the culprit lesion group. Thirty patients
ied due to a cardiac cause (11.1% cardiovascular mortality).
hey were all part of the culprit lesion group. Patients died
ue to acute fatal myocardial infarction in 15 cases and due
o heart failure in the other 15. Overall, 41 patients suffered
rom a coronary event (30 cardiac deaths and 11 nonfatal
yocardial infarcts); none of them belonged to the group
ithout culprit lesion. Statistical analysis revealed signif-
cant differences between patients with and without
ulprit lesion for sex, age, left ventricular ejection frac-
ion, and troponin I levels (p  0.05) (Table 1). There
ere no differences when comparing patients with and
ithout coronary spasm (Table 2).
redictive factors. Univariate Cox regression analysis re-
ealed the presence of a culprit lesion, age, left ventricular
jection fraction, and troponin I levels as predictors for
ll-cause death and coronary events. After multivariate Cox
egression analysis, age and left ventricular ejection fraction
emained as independent predictors (Table 3).
Culprit Lesion Absent Total p Value
76 346
34 (45%) 225 (65%) 0.0001
65 (54–71) 68 (59–76) 0.0001
70 (62–78) 61 (48–72) 0.0001
0.02 (0.02–0.02) 1.92 (0.04–29) 0.0001
1 (1%) 52 (15%) 0.0001
0 30 (8.7%) 0.001
0 11 (3.2%) 0.131
38 (50%) 116 (33.5%) 0.001
3 (3.9%) 30 (8.7%) 0.110
6 g/l.
esionout Culprit Lesion
onary Spasm on ACH Testing
p ValueAbsent
39
16 (41%) 0.645
62 (54–73) 0.406
70 (62–77) 1.000
0.02 (0.02–0.02) 0.268
1 (2.6%) 1.000
0 1.000
0 1.000
21 (54%) 0.492
2 (5.1%) 1.000s
tprit LWith
ial Cor
nt
)
0)
9)
–0.38)
)
)6 g/l.
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ACS Patients With Coronary Spasm: 3-Year Follow-Up January 11, 2011:147–52In patients without culprit lesion, 59 (69%) of the initial
6 who underwent ACH testing had reproduction of angina
uring ACH infusion. Among the 76 patients in whom
ollow-up data were available, 53 (70%) had angina during
nitial ACH testing, 38 (50%) had recurrent angina at
ollow-up, and 25 (33%) had both. Comparison of patients
ith angina at the initial ACH test and those with recurrent
ngina at follow-up revealed no statistically significant
ssociation (p  0.448). Ischemic ECG shifts during initial
Figure 2 Kaplan-Meier Survival Curves: All-Cause Mortality
Kaplan-Meier survival curves (cumulative survival) for all-cause mortality show-
ing significantly more deaths in the group with culprit lesion (cl , green) than
in the group without (cl , blue) (p  0.0005, log-rank test) during follow-up
(1,095 days). The number of patients alive during follow-up is given below the
graph. Cum  cumulative.
nivariate and Multivariate Cox Regression Analysisor All-Cause Death and Coronary EventTable 3 Univariate and Multivariate Cox RegressionAnalysis for All-Cause Death and Coronary Events
Univariate Multivariate
All-cause death
Culprit lesion 15.809 (2.185–114.406), 0.006 3.707 (0.482–28.524), 0.208
Sex 0.899 (0.503–1.604), 0.718 1.062 (0.519–2.173), 0.868
Age 1.072 (1.042–1.103),0.0005 1.058 (1.023–1.094), 0.001
LVEF 0.951 (0.935–0.968),0.0005 0.964 (0.945–0.983),0.0005
Troponin I* 1.008 (1.005–1.011),0.0005 1.003 (1.000–1.007), 0.086
Coronary events
Culprit lesion 30.425 (1.382–669.927), 0.030 3.439 (0.440–26.897), 0.239
Sex 1.092 (0.578–2.062), 0.786 1.200 (0.535–2.692), 0.658
Age 1.063 (1.031–1.097),0.0005 1.053 (1.014–1.093), 0.008
LVEF 0.957 (0.939–0.976),0.0005 0.972 (0.951–0.994), 0.011
Troponin I* 1.007 (1.004–1.011),0.0005 1.003 (0.998–1.007), 0.230
alues are hazard ratio (95% confidence interval), p value. *Normal troponin I 0.16 g/l.
LVEF  left ventricular ejection fraction.CH testing were observed in 35 out of 86 patients (41%),
f whom 14 had recurrent angina at follow-up. There was
o statistically significant association between patients who
howed ischemic ECG shifts at initial ACH testing and
hose with recurrent angina at follow-up (p  0.999). The
IMI frame count analysis revealed a slow coronary flow
henomenon in at least 1 coronary artery in 10 out of 86
atients (12%), of whom 2 (2%) showed slow flow in all 3
essels. Although 6 of the latter 10 patients reported
ecurrent angina at follow-up (60%), comparison of patients
ith slow coronary flow (n  10) and those with recurrent
ngina at follow-up (n  38) did not reveal the slow
oronary flow phenomenon as a predictor of recurrent
ngina (p  0.480).
urvival curves. Kaplan-Meier analysis showed a signifi-
antly higher all-cause mortality in patients with culprit
esion compared with those without (p  0.0005, log-rank
est) (Fig. 2). Comparison of coronary events between the 2
atter groups equally disclosed a significant difference (p 
.0005, log-rank test) (Fig. 3).
iscussion
his is the first study, to our knowledge, reporting an
xcellent prognosis regarding survival and coronary events in
aucasian patients with documented coronary spasm as
ause for ACS.
Figure 3 Kaplan-Meier Survival Curves: Coronary Events
Kaplan-Meier curves (cumulative survival) comparing coronary events in
patients with and without culprit lesion. The culprit lesion group (cl , green)
had significantly more events than the group without culprit lesion (cl , blue)
(p  0.0005, log-rank test) during follow-up (1,095 days). The number of
patients without coronary events during follow-up is given below the graph.
Cum  cumulative.
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January 11, 2011:147–52 ACS Patients With Coronary Spasm: 3-Year Follow-Upatients with culprit lesion. The unfavorable outcome
egarding survival and coronary events in patients with
ulprit lesion is in line with other studies (7). It can be
xplained by the fact that these patients were more often
ale and had higher biomarker levels of troponin at study
ntry, corresponding to a larger amount of myocardial
amage. Consequently, patients with culprit lesion had a
ower left ventricular ejection fraction and a higher risk for
ardiac events (8).
atients without culprit lesion. Patients without culprit
esion showed no cardiac death or nonfatal myocardial
nfarction during follow-up. This is compatible with previ-
us reports (9,10). The favorable outcome of our patients
ithout culprit lesion could be related to the fact that they
ost often presented with unstable angina (n  70) rather
han non–ST-segment elevation myocardial infarction
NSTEMI) (n  5) or ST-segment elevation myocardial
nfarction (STEMI) (n 1), supporting the hypothesis that
rolonged coronary spasm can mimic true obstructive ACS
ut usually with only little myocardial damage (11).
Other studies, though, have described a higher incidence
f cardiac death and nonfatal myocardial infarction in
ubsets of patients with coronary artery spasm (12,13).
annebicque et al. (14) reported that 10.6% of 210 coronary
pasm patients suffered a myocardial infarct during a mean
ollow-up of 55 months. However, infarcts only occurred in
atients who had spasm in the setting of obstructive
oronary artery disease at baseline angiography. Bory et al.
15) described long-term follow-up of 277 French, mainly
on-ACS patients with coronary spasm and unobstructed
oronary arteries. In this group, 3.6% suffered from cardiac
eath and 6.5% from myocardial infarction after a median
ollow-up of 89 months. This difference might be due to the
ifferent inclusion criteria. Of importance, 71.5% of the
ory et al. (15) patients were smokers, compared with only
3.8% in our study. Smoking can lead to constant and severe
ndothelial damage and likely contributes to a higher
usceptibility for spasm-related myocardial infarction
16,17). The better outcome in our patients may also be
elated to stringent treatment of all patients with
ngiotensin-converting enzyme inhibitors, statins, and in-
ividually titrated combinations of calcium antagonist and
itrates.
Data on prognosis in Asian ACS patients with coronary
pasm and insignificant coronary artery disease are sparse.
ang et al. (3) showed a good outcome regarding cardiac
eath in their 93 Japanese ACS patients with unobstructed
oronary arteries. However, there were 2 nonfatal myocar-
ial infarctions among the patients with proof of coronary
pasm (5.3%) at a median follow-up of 25 months. The
igher incidence of myocardial infarcts compared to our
tudy might be due to the different inclusion criteria because
he Wang et al. (3) study comprised more NSTEMI
atients. Furthermore, a different genetic background in
sian compared with Caucasian patients leading to a higher
revalence of coronary spasm could explain these differences fi5). Nakayama et al. (18) showed that mutations in the
ndothelial nitric oxide synthase gene in Japanese patients
an predispose to coronary spasm.
A sizeable proportion of patients without coronary spasm
ad persistent angina and repeated coronary angiography
uring follow-up (Table 2). However, importantly, in pa-
ients with a “negative” ACH test, only 4 had no relevant
asoconstriction and no symptoms during ACH testing.
he other patients had either reproduction of symptoms
nd/or an intermediate vasoconstriction during ACH infu-
ion. Furthermore, TIMI frame count analysis revealed a
low coronary flow phenomenon in 10 patients of the initial
6 who underwent ACH testing in at least 1 coronary artery
12%), of whom 4 patients had no coronary spasm during
CH infusion.
These findings could possibly be explained by an abnor-
al coronary vasoreactivity of the coronary microcircula-
ion. In this group of patients, abnormalities of the coronary
icrocirculation resulting in a reduced coronary reserve or
icrovascular spasm (19) could have caused repetitive an-
ina during exercise or at rest (20). In fact, it has been
eported that coronary microvascular dysfunction can be the
eason for acute chest pain at rest and ACS (21,22). These
esults suggest that microvascular abnormalities during
CH testing should be pursued as these patients might
equire medical treatment and follow-up in a similar way to
hose with epicardial coronary spasm.
The fact that our patients without culprit lesion required
epeated coronary angiography in only 4% of cases is
ifferent from previously reported studies. Johnson et al.
23) reported about 21% of patients requiring repeated
ngiography during 3-year follow-up in women with chest
ain, normal coronary arteries, and evidence of myocardial
schemia. The fact that coronary vasospasm was established
n our patients as the true cause of the patients symptoms
ollowed by initiation of medical treatment (i.e., calcium-
hannel blocker and nitrates) might have avoided the
requent reassessment as described in the other less well-
haracterized cohorts.
linical implications. Patients with ACS without culprit
esion seem to have an excellent prognosis regarding overall
urvival and coronary events. Intracoronary acetylcholine
rovocation is suggested for the identification of epicardial
oronary spasm. Despite antispastic treatment, recurrent
hest pain continues to be a challenging problem in these
atients. Therefore, management plans should not only
ntegrate institution of appropriate therapy at the time of
iagnosis (i.e., angiotensin-converting enzyme inhibitors,
tatins, calcium-channel blockers, and nitrates) but also
nclude follow-up with adjustment of antianginal therapy.
tudy limitations. Although, after establishing the diag-
osis of coronary spasm, a standardized treatment including
calcium-channel blocker and nitrates was initiated, the
edication during follow-up was not systematically modi-ed with regard to the patients’ symptoms. The numbers for
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ACS Patients With Coronary Spasm: 3-Year Follow-Up January 11, 2011:147–52ersistent angina might have been different if treatment had
een adjusted during follow-up.
Furthermore, it cannot be excluded that patients lost to
ollow-up may have suffered from an adverse event. How-
ver, in our opinion, the likelihood of patients without
ulprit lesion and missing follow-up data having suffered
rom events is very low. This is supported by the small
umber of patients lost to follow-up in this group (n  10)
ompared with 80 in the group with culprit lesion and the
act that all of the latter 10 patients had a normal left
entricular ejection fraction (60%) and also no elevation of
roponin I concentrations (0.02 g/l).
onclusions
aucasian patients with ACS, no culprit lesion, and coro-
ary spasm have an excellent and significantly better prog-
osis for survival and coronary events after 3 years compared
ith patients with culprit lesion. The favorable outcome
ight be related to the small amount of myocardial damage,
s patients without culprit lesion most often presented with
nstable angina rather than NSTEMI or STEMI. How-
ver, recurrent angina represents a challenging problem in
hese patients, leading in some cases to repeated coronary
ngiography.
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